Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BAY-2416964 is an antagonist of the aryl hydrocarbon receptor (AhR; IC50 = 22 nM in U87 cells).1 It decreases the mRNA expression of the AhR target genes CYP1A1 and AHRR induced by the AhR agonist kynurenic acid (Item No. 16792) in LPS-stimulated isolated human monocytes when used at a concentration of 100 nM. BAY-2416964 (30-1,000 nM) increases CD3-, CD28-, and IL-2-induced IFN-γ production in isolated human naïve CD4+ T cells. In vivo, BAY-2416964 (30 mg/kg, p.o.) reduces tumor volume, increases CD8+ T cell and natural killer (NK) cell tumor infiltration, and decreases GR1+ myeloid cell and CD206+ M2 macrophage tumor infiltration in a B16/F10-OVA murine melanoma model.
WARNING This product is not for human or veterinary use.
1. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: A selective small molecule inhibitor for cancer immunotherapy. J. Immunother. Cancer 11(11), e007495 (2023).